Bortezomib: Clinical Trials

4 trials for Bortezomib, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

4 unknown. 1 Not applicable, 1 Phase 1, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Not applicable1Unknown 1
Phase 11Unknown 1
Phase 21Unknown 1

Follow Bortezomib: new trials by email Literature Review of Bortezomib trials Research Report on Bortezomib

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Bortezomib for Treating Glomerular Diseases
Bortezomib - Bortezomib, Glomerulonephritis
Not applicableUnknownRuijin Hospital202022-08-022022-10-31
Bortezomib Combined With DAG Regimen in the Treatment of Refractory/Relapsed AML
DAG pre-excitation regimen with Bortezomib - Bortezomib, Acute Myeloid Leukemia
Phase 1UnknownZhongnan Hospital402020-01-012023-08-09
Evaluation of Clinical Treatment of Multiple Myeloma Based on Multi-omics
Bortezomib - Multiple Myeloma, Bortezomib
UnknownBeijing Chao Yang Hospital3502019-05-162022-04-28
Combination of G-CSF, Bortezomib, Cyclophosphamide and Dexamethasone in Patients With Multiple Myeloma
G-CSF, Bortezomib, Cyclophosphamide - Myeloma, Bortezomib
Phase 2UnknownSecond Affiliated Hospital of Soochow University602013-12-012014-01-06

Narrower conditions

Glomerulonephritis (1)  ·  Glomerulonephritis, IGA (1)  ·  Leukemia, Myeloid, Acute (1)  ·  Multiple Myeloma (1)  ·  Neoplasms, Plasma Cell (1)

Broader conditions

Neoplasms (3)  ·  Neoplasms by Histologic Type (3)  ·  Hematologic Diseases (2)  ·  Hemic and Lymphatic Diseases (2)  ·  Immune System Diseases (2)  ·  Autoimmune Diseases (1)  ·  Blood Protein Disorders (1)  ·  Cardiovascular Diseases (1)  ·  Female Urogenital Diseases (1)  ·  Female Urogenital Diseases and Pregnancy Complications (1)  ·  Hemorrhagic Disorders (1)  ·  Hemostatic Disorders (1)  ·  Immunoproliferative Disorders (1)  ·  Kidney Diseases (1)  ·  Leukemia (1)

Interventions

Bortezomib (4)  ·  Cyclophosphamide (1)  ·  Dexamethasone (1)  ·  Granulocyte Colony-Stimulating Factor (1)

Sponsors

Beijing Chao Yang Hospital (1)  ·  Ruijin Hospital (1)  ·  Second Affiliated Hospital of Soochow University (1)  ·  Zhongnan Hospital (1)

Countries

China (4)

Top investigators

Fuling Zhou, phD (1)  ·  Jinxiang Fu, M.D., PhD (1)  ·  Lihong Liu, Doctor (1)

Results publications

PMID 38724717